Articles From: Record-Breaking "New England SkyScreamer" is Now Open at Six Flags New England to Regado Biosciences Announces Pricing of Public Offering of Common Stock


2014/5/15
New England's Largest Theme Park Introduces the Tallest Swing Ride on the Planet AGAWAM, Mass.
Sign-up for Record-Breaking "New England SkyScreamer" is Now Open at Six Flags New England investment picks
2014/4/3
VANCOUVER, British Columbia, April 3, 2014 (GLOBE NEWSWIRE) -- Investors don't mind investing in a promising gold play.
Sign-up for Recreating Endeavour's Success investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0939945001&sourceType=1 TORONTO, ONTARIO --
Sign-up for Red Crescent Resources Limited: Ebullio Mining Refuses to Close Transaction investment picks
2014/5/8
http://media.marketwire.com/attachments/201311/68794_redgiantlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1113880&ProfileId=051205&sourceType=1 ORLANDO, FL --
Sign-up for Red Giant Entertainment Reports Hit Debut of New Graphic Novel Line at Free Comic Book Day investment picks
2014/5/13
http://media.marketwire.com/attachments/201206/55916_RGEMarketwireLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1115101&ProfileId=051205&sourceType=1 ORLANDO, FL --
Sign-up for Red Giant Entertainment to Attend 'E3 2014,' Premier Gaming Trade Show in Los Angeles in June investment picks
SPOKANE, Wash., April 17, 2014 (GLOBE NEWSWIRE) -- Red Lion Hotels Corporation (NYSE:RLH) will report first quarter 2014 earnings results after the market closes on Wednesday, April 30, 2014.
Sign-up for Red Lion Announces First Quarter 2014 Earnings Conference Call to be held May 1 investment picks
SPOKANE, Wash., April 28, 2014 (GLOBE NEWSWIRE) -- Red Lion Hotels Corporation (NYSE:RLH) has earned a 2014 Visionary Award from Hospitality Technology (HT) magazine for its complete rewrite of all public-facing technologies in the consumer website.
Sign-up for Red Lion Earns National Award for Customer-Facing Technology investment picks
SPOKANE, Wash., May 21, 2014 (GLOBE NEWSWIRE) -- Red Lion Hotels Corporation (NYSE:RLH) announced the company has named Brian Quinn as Senior Vice President and Chief Franchise Officer.
Sign-up for Red Lion Hotels Appoints Brian Quinn as Chief Franchise Officer investment picks
SPOKANE, Wash., April 30, 2014 (GLOBE NEWSWIRE) -- Red Lion Hotels Corporation (NYSE:RLH) , a western U.S. based owner, operator and franchisor of midscale hotels, today announced its results for the first quarter ended March 31, 2014.
Sign-up for Red Lion Hotels Reports First Quarter 2014 Results investment picks
SPOKANE, WA, May 7, 2014 (GLOBE NEWSWIRE) -- Red Lion Hotels Corporation (NYSE:RLH) announced today its franchise hotel, the Red Lion Inn & Suites Kennewick, was recently sold and the new owner has entered into a franchise agreement to continue to operate the hotel under the brand.
Sign-up for Red Lion Hotels Signs New Franchise Agreement for Red Lion Inn & Suites Kennewick investment picks
SPOKANE, WASH., May 5, 2014 (GLOBE NEWSWIRE) -- Red Lion Hotels Corporation (NYSE:RLH) has entered into an agreement with Sceptre Hospitality Resources (SRH) to configure WindsurferCRS as the premise of its reservation platform and provide unprecedented access to reservation, distribution and reporting information.
Sign-up for Red Lion Hotels to Deploy New Central Reservation System Powered by WindsurferCRS investment picks
SPOKANE, Wash., April 15, 2014 (GLOBE NEWSWIRE) -- Red Lion Hotels Corporation (NYSE:RLH) today announced the addition of Angela Landgraf as Senior Vice President of Business Development.
Sign-up for Red Lion Intensifies Development with Addition of Angela Landgraf investment picks
SPOKANE, Wash., March 31, 2014 (GLOBE NEWSWIRE) -- Red Lion Hotels Corporation (NYSE:RLH) announced the company is launching a multi-channel online spring promotion designed to increase reservations, acquire new customers and grow brand awareness.
Sign-up for Red Lion Launches Multi-Channel Spring Promotion investment picks
SPOKANE, WA, May 22, 2014 (GLOBE NEWSWIRE) -- Red Lion Hotels Corporation (NYSE:RLH) announced the company has sold its property in Kelso/Longview, Wash., to new owners who signed a franchise agreement with a property improvement plan.
Sign-up for Red Lion Sells Kelso Hotel and Enters into Franchise Agreement investment picks
SPOKANE, WA, April 11, 2014 (GLOBE NEWSWIRE) -- Red Lion Hotels Corporation (NYSE:RLH) today announced the company has sold the Red Lion Hotel Yakima in Washington.
Sign-up for Red Lion Sells Yakima Hotel and Enters Franchise Agreement investment picks
Enables lower pressures over the course of the night than standard APAP SAN DIEGO , May 21, 2014 /PRNewswire/ -- A new study presented today at the American Thoracic Society 2014 International Conference (Abstract #714) indicates that a new algorithm developed specifically for how female sleep apnea sufferers breathe and who use auto-adjusting positive airway pressure (APAP) therapy can improve flow limitation and enable lower pressures for therapy, leading to a more comfortable therapy experience.
Sign-up for Redefining Sleep Apnea Treatment for Women: New Algorithm Significantly Improves Treatment of Flow Limitation investment picks
FDA's clearance of RedHill's Investigational New Drug ("IND") amendment allows the initiation of a Phase III clinical study for a new undisclosed indication with RHB-102 1 , a proprietary, once-daily, extended release oral pill formulation of the antiemetic drug ondansetron In parallel to pursuing the new undisclosed indication, RedHill is pursuing marketing approval of RHB-102 for the indications of chemotherapy and radiotherapy-induced nausea and vomiting ("CINV" and "RINV" respectively) in Europe and the U.S. TEL-AVIV, Israel, May 22, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd.
Sign-up for RedHill Biopharma Announces FDA Clearance for Phase III Study With RHB-102 Planned to Commence in Q3/2014 investment picks
The Company concluded a positive scientific advice meeting with the UK MHRA regarding RHB-102 and plans to submit, during the second half of the year, a European marketing application for the prevention of chemotherapy and radiotherapy-induced nausea and vomiting in cancer patients RHB-102 is a proprietary, once-daily, oral pill formulation of the anti-emetic oncology support drug ondansetron The Company commenced a comparative bioavailability study with RHB-102 to support its planned European marketing application, with study results expected by July 2014 In addition to the currently pursued indications, the MHRA provided guidance regarding a new undisclosed indication which may significantly expand RHB-102's potential market; A Phase III study for this indication is planned in the U.S. for later this year TEL-AVIV, Israel, April 7, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd.
Sign-up for RedHill Biopharma Announces Positive European Scientific Advice Meeting Regarding RHB-102 and Plans to Submit a European Marketing Application investment picks
Key financial highlights include: TEL-AVIV, Israel, April 30, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd.
Sign-up for RedHill Biopharma Reports Results for the First Quarter of 2014 investment picks
RedHill received positive results from a comparative bioavailability clinical trial which included 20 healthy volunteers In light of the positive results, and subject to regulatory requirements, the Company plans to submit, during the third quarter of this year, a European marketing application for RHB-102 for the prevention of chemotherapy and radiotherapy-induced nausea and vomiting in cancer patients RHB-102 is a proprietary, once-daily, extended release oral pill formulation of the anti-emetic oncology support drug ondansetron RedHill is also pursuing a new undisclosed indication for RHB-102, which may significantly expand its potential market, with a Phase III study planned to commence in the U.S. later this year TEL-AVIV, Israel, April 30, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd.
Sign-up for RedHill Biopharma Reports Successful RHB-102 Bioavailability Clinical Trial and Planned Submission of European Marketing Application in Q3/2014 investment picks
TEL-AVIV, Israel, April 29, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd.
Sign-up for RedHill Biopharma to Host First Quarter 2014 Financial Results Conference Call on May 1, 2014 investment picks
TEL-AVIV, Israel, May 1, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd.
Sign-up for RedHill Biopharma to Present at the ChinaBio Partnering Forum 2014 investment picks
2014/4/28
Quarterly roundtables uncover key challenges and best practices in trade expense visibility and management LAKE SUCCESS, N.Y. , April 28, 2014 /PRNewswire/ -- Broadridge Financial Solutions , Inc. (NYSE:BR) today released findings from a series of quarterly roundtables where operations, finance and technology professionals from leading global banks discussed key challenges and best practices in trade expense management.
Sign-up for Reducing Trade Execution Expenses and Gaining Transparency are Top of Mind for Leading Global Banks, according to Broadridge investment picks
MILL VALLEY, Calif.
Sign-up for Redwood Trust Announces Timing For First Quarter 2014 Earnings Release And Call investment picks
MILL VALLEY, Calif.
Sign-up for Redwood Trust Declares $0.28 Per Share Dividend For The Second Quarter Of 2014 investment picks
MILL VALLEY, Calif.
Sign-up for Redwood Trust Reports First Quarter 2014 Results investment picks
2014/4/10
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1105748&ProfileId=051205&sourceType=1 EVERETT, WA --
Sign-up for ReelTime Partners Begins Development of Reality Television Series "Plane Nuts" investment picks
Combines ST's "Cannes/Monaco" family of HEVC Decoder SoCs with MaxLinear Full-Spectrum Capture TM Four- or Eight-Channel MxL5xx Front-End ICs CARLSBAD, Calif.
Sign-up for Reference Design from MaxLinear and STMicroelectronics to Speed Multi-Channel Ultra HD HEVC Satellite STB & Gateway Deployments investment picks
BASKING RIDGE, N.J. , April 16, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO) , today announced the closing of its previously announced underwritten public offering.
Sign-up for Regado Biosciences Announces Closing of Public Offering of Common Stock investment picks
BASKING RIDGE, N.J. , April 11, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO) , today announced the pricing of its previously announced underwritten public offering of 10,000,000 shares of its common stock, offered at a price of $6.00 per share to the public.
Sign-up for Regado Biosciences Announces Pricing of Public Offering of Common Stock investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Record-Breaking "New England SkyScreamer" is Now Open at Six Flags New England to Regado Biosciences Announces Pricing of Public Offering of Common Stock
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry